ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension
2016 · Alzheimer s Research & Therapy · 38 citations
https://doi.org/10.1186/s13195-016-0210-1